17h
Hosted on MSNAlphamab doses first subject in trial of JSKN003 for ovarian cancerAlphamab Oncology has dosed the first subject in the randomised Phase III JSKN003-306 trial of its anti-human epidermal ...
17h
Parade on MSNThe Early Ovarian Cancer Sign Most People Miss, According to OB/GYNsRelated: Shannon Miller on Her Ovarian Cancer Diagnosis. The Early Ovarian Cancer Sign Most People Miss. According to experts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results